Bristol-Myers Squibb Company Reduces Workforce Amid Restructuring

Bristol-Myers Squibb Company has laid off approximately 300 employees as part of a restructuring effort aimed at streamlining operations. The layoffs occurred in early October 2023 and are part of the company's strategy to enhance efficiency and focus on core business areas. This decision reflects the ongoing challenges in the biopharma sector, where companies are adjusting their workforce to align with market demands. The affected employees were primarily based in New Jersey, although specific departments were not disclosed. This move is seen as a necessary step for the company to maintain competitiveness in a rapidly evolving industry.

LayoffTalk has tracked 30 layoff events at Bristol-Myers Squibb Company since November 2022, including 4,575 jobs documented in official WARN filings, with 17 additional events known from news reporting.